Citra-Gen AG develops, manufactures and sells medical products for central venous access in renal therapy, hematology and oncology. Its product range includes Citra-Lock, a citrate catheter lock solution, Citra-Lock prefilled syringes, Citra-XS catheters and wound management products. Citra-Lock is referenced in clinical guidelines such as ERBP and ASDIN.
AI-generated
Offering
Products & services
Industry:Wholesale - Health & Cosmetic Products
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Catheter lock solutions based on citrate in vials and prefilled syringes; anti-clotting and antimicrobial, for central catheters in renal replacement therapy, haematology and oncology.
Catheters for short-term access
Catheter sets for short-term central venous access, including Victoria Short Term and Joline® Short Term, for Seldinger insertion and clinical use.
Catheters for long-term access
Catheter sets for long-term central venous access, including Superior Long Term and Nile Long Term, for clinical applications with split tip or shotgun tip.
Wound management
Wound management products, including WoundClot Surgical and WoundClot Dialysis, for internal applications and sterile single-use applications.
Production and distribution of central venous access products
Development, manufacturing and sale of central venous access products in renal therapy, haematology and oncology.
Knowledge
No knowledge articles yet
Once Citra-Gen AG has claimed this profile, we'll publish editorial articles and case studies here together.